BridgeBio Pharma Inc (BBIO) with a beta value of 1.08 appears to be a promising investment opportunity.
On Monday, BridgeBio Pharma Inc (NASDAQ: BBIO) opened higher 2.52% from the last session, before settling in for the closing price of $23.84. Price fluctuations